Inhibrx Biosciences Inc. (INBX)
13.35
0.61 (4.79%)
At close: Jan 15, 2025, 3:32 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | -7.42 | -6.8 | -20.3 | -11.01 | -14.67 | -17.93 | -30.55 | -91.2 |
| PS Ratio | 994.97 | 453.75 | 232.97 | 65.03 | 82.93 | 74.48 | 74.71 | 113.11 |
| PB Ratio | 41.17 | 17.02 | 31.69 | 11.04 | -8.06 | -9.69 | -20.64 | -81.55 |
| P/FCF Ratio | -9.05 | -8.52 | -20.45 | -16.88 | -22.25 | -22.78 | -29.56 | -41.16 |
| P/OCF Ratio | -9.26 | -8.57 | -20.67 | -17.36 | -23.51 | -24.19 | -31.67 | -41.65 |
| OCF/S Ratio | -107.39 | -52.94 | -11.27 | -3.75 | -3.53 | -3.08 | -2.36 | -2.72 |
| Debt / Equity Ratio | 4.83 | 3.48 | 1.35 | 0.50 | -0.45 | -0.16 | -0.51 | -2.05 |
| Quick Ratio | 5.25 | 10.18 | 6.23 | 8.33 | 0.60 | 0.21 | 1.62 | 3.87 |
| Current Ratio | 5.25 | 10.17 | 6.20 | 4.21 | 0.76 | 0.35 | 1.73 | 3.87 |
| Asset Turnover | 0.01 | 0.01 | 0.05 | 0.09 | 0.34 | 0.75 | 0.46 | 0.31 |
| Interest Coverage | -6.89 | -8.02 | -14.68 | -6.24 | -7.64 | -19.94 | -9.28 | n/a |
| Return on Equity (ROE) | -5.55 | -2.5 | -1.56 | -1 | 0.55 | 0.54 | 0.68 | 0.89 |
| Return on Assets (ROA) | -0.78 | -0.5 | -0.54 | -0.53 | -1.94 | -3.12 | -1.13 | -0.39 |
| Return on Capital (ROIC) | -0.87 | -0.49 | -0.6 | -0.6 | -7.39 | 4.76 | -2.37 | -0.76 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | -0.03 | -0.07 | n/a |
| Gross Profit Margin | 33.83% | -30.67% | 62.27% | -473.82% | -426.86% | -346.05% | -220.88% | -154.87% |
| Net Profit Margin | -13.41K% | -6.67K% | -1.15K% | -590.54% | -565.27% | -415.51% | -244.55% | -124.03% |
| Pretax Profit Margin | -13.32K% | -6.67K% | -1.15K% | -590.52% | -555.39% | -412.33% | -274.59% | -193.27% |
| Operating Profit Margin | -12.18K% | -5.93K% | -1.07K% | -526.57% | -480.74% | -393.51% | -248.15% | -182.18% |
| FCF Margin | -10.99K% | -5.33K% | -1.14K% | -385.17% | -372.69% | -326.95% | -252.73% | -274.83% |
| EBITDA Margin | -11.48K% | -5.78K% | -1.07K% | -526.57% | -468.54% | -383.59% | -242.83% | -178.39% |